Lipoprotein(a) is not associated with active calcification of the aortic valve in patients with mild-to-moderate aortic stenosis, according to a study presented this week at the European ...

(UPDATED) Lipoprotein(a) is associated with the development of aortic valve calcification (AVC), but the atherogenic lipoprotein does not appear to be linked to the progression of calcification over ...

Recent research from Karl Landsteiner University of Health Sciences (KL Krems) provides important new insights into how aortic valve size is associated with the degree of valve calcification in severe ...

Researchers have now proposed a molecular mechanism that links amyloid deposition in the aortic valve with degenerative calcification. They also theorize that other risk factors for CAVD, such as high ...

Mechanisms of heart-valve disease often mimic processes observed in embryonic and early childhood development, including activation of valvular interstitial cell (VIC) phenotypes and remodeling of ...

Aortic stenosis, a major contributor to global cardiovascular morbidity, is expected to increase in prevalence as populations ...

In patients greater than age 65, more than 90% of aortic stenosis involves trileaflet valves which have developed heavy calcification. [5] In these instances the calcium deposits are thought to alter ...

There may be relationships between bone mineral density at different body locations and cardiac calcification. Sex-specific differences may exist in these relationships. Further research is needed to ...

The endothelium lining the valve plays a critical role. It’s very important whether the valve consists of two or three leaflets. There is currently no way to stop calcification of the aortic valve. If ...

Why it matters: Millions live with undiagnosed valvular heart disease, which can lead to heart failure, stroke, or death if untreated. What’s causing it: Valve narrowing and calcification can result ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...

Please provide your email address to receive an email when new articles are posted on . A first-of-its-kind therapy successfully slowed plaque progression in patients with aortic stenosis. Ataciguat ...